Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 135
Filtrar
2.
Medicine (Baltimore) ; 100(33): e27009, 2021 Aug 20.
Artículo en Inglés | MEDLINE | ID: mdl-34414994

RESUMEN

INTRODUCTION: Right heart free-floating thrombus in the absence of structural heart disease or atrial fibrillation is rare. When it travels to the heart into the lung, called thrombus-in-transit, may cause cardiopulmonary collapse and sudden death. The clinical presentation varies from mild respiratory symptoms to sudden death; however, there are few clinical case reports of giant, free-floating thrombus in the right heart in an asymptomatic patient, and the optimal management options have not been established. PATIENT CONCERNS: A 36-year-old Asian woman presented to the emergency department with complaints of worsening swelling of the left lower extremity over 12 hours. DIAGNOSIS: Left leg deep vein thrombosis accompanied by an asymptomatic giant right atrial thrombus and pulmonary embolism with a rare autoimmune disease of Evans syndrome. INTERVENTIONS: Emergent surgical thrombectomy under cardiopulmonary bypass for right atrial thrombus. OUTCOMES: The postoperative course was uneventful, and she was discharged on the eighth postoperative day with normal heart function and mild tricuspid regurgitation. CONCLUSION: An additional diagnostic workup in cases of deep vein thrombosis is necessary for the rapid diagnosis of right heart thrombus and pulmonary embolism without delay. This case report illustrates that early recognition of venous thromboembolism and emergent thrombectomy of right heart thrombus-in-transit is crucial to prevent mortality.


Asunto(s)
Corazón/diagnóstico por imagen , Trombosis/diagnóstico , Adulto , Anemia Hemolítica Autoinmune/fisiopatología , Ecocardiografía/métodos , Femenino , Humanos , Trombocitopenia/fisiopatología , Trombosis/fisiopatología
4.
Pan Afr Med J ; 38: 314, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-34285737

RESUMEN

This manuscript concerns the case of a patient hospitalized and diagnosed with Evans syndrome. She was hospitalized with signs of thrombocytopenia induced purpura, petechiae, ecchymosis and anemia. She was successfully treated with corticoids and blood transfusions. Our purpose is to explain her clinical presentation and the exams, we used in order to make the diagnosis of Evans syndrome, which requires great suspicion. Moreover, other diseases causing hemolytic anemia and thrombocytopenia must be excluded. We used laboratory tests (blood samples, Coombs examination and virologic test). Bone marrow examination took place twice. Evans syndrome is an autoimmune disease which is characterized by the coexistence of hemolytic anemia and immune-mediated thrombocytopenia. There is no typical clinical presentation. Its etiology is unknown and its therapy is generally poor. Diagnosis of Evans syndrome is very difficult and requires the exclusion of other diseases causing anemia and thrombocytopenia.


Asunto(s)
Anemia Hemolítica Autoinmune/diagnóstico , Trombocitopenia/diagnóstico , Anciano de 80 o más Años , Anemia Hemolítica Autoinmune/fisiopatología , Anemia Hemolítica Autoinmune/terapia , Transfusión Sanguínea/métodos , Diagnóstico Diferencial , Femenino , Glucocorticoides/administración & dosificación , Humanos , Trombocitopenia/fisiopatología , Trombocitopenia/terapia
5.
Ann Clin Lab Sci ; 51(2): 213-219, 2021 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-33941561

RESUMEN

OBJECTIVE: Patients with warm autoimmune hemolytic anemia (WAIHA) present with anemia that is highly heterogeneous, and often have macrocytic anemia with inappropriately elevated mean corpuscular volume (MCV). The goal of this retrospectivecase study is to elucidate the characteristics of anemia in patients with idiopathic WAIHA. PROCEDURES: The hematological parameters were analyzed by automated hematology analyzers in 19 consecutive patients with idiopathic WAIHA. Thecontent of hemoglobin (Hb) in the reticulocytes was assessed as reticulocyte Hb equivalent (RET-He). Relevant laboratory data and medical records were retrospectively studied. RESULTS: The median MCV was 102.7 fL and ten patients had macrocytic anemia with MCV above 100 fL. There was a significant correlation between the percentage of reticulocytes and MCV. The median RET-He value was 35.9 pg, and the reticulocytes of patients with higher MCV had higher RET-He. There was a significant correlation between red cell volume distribution width (RDW) andMCV, while the association between RDW and RET-He was not significant. Red blood cell agglutination was not seen in any of the patients. Relative folate deficiency was implied to contribute to the increased Hb content in the reticulocytes of WAIHA patients. CONCLUSION: Reticulocytes in WAIHA patients often contain more Hb than normal reticulocytes and become inappropriately large, possibly due to relative folate deficiency. Elevated MCV in WAIHA patients is due to the increase in both the number and the Hb content of reticulocytes.


Asunto(s)
Anemia Hemolítica Autoinmune/metabolismo , Anemia Macrocítica/diagnóstico , Reticulocitos/química , Adulto , Anciano , Anciano de 80 o más Años , Anemia/diagnóstico , Anemia Hemolítica Autoinmune/fisiopatología , Anemia Macrocítica/metabolismo , Índices de Eritrocitos/fisiología , Femenino , Hemoglobinas/análisis , Hemoglobinas/química , Humanos , Japón , Masculino , Persona de Mediana Edad , Estudios Retrospectivos
6.
Ann Rheum Dis ; 80(1): 14-25, 2021 01.
Artículo en Inglés | MEDLINE | ID: mdl-33051219

RESUMEN

Clinical heterogeneity, unpredictable course and flares are characteristics of systemic lupus erythematosus (SLE). Although SLE is-by and large-a systemic disease, occasionally it can be organ-dominant, posing diagnostic challenges. To date, diagnosis of SLE remains clinical with a few cases being negative for serologic tests. Diagnostic criteria are not available and classification criteria are often used for diagnosis, yet with significant caveats. Newer sets of criteria (European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) 2019) enable earlier and more accurate classification of SLE. Several disease endotypes have been recognised over the years. There is increased recognition of milder cases at presentation, but almost half of them progress overtime to more severe disease. Approximately 70% of patients follow a relapsing-remitting course, the remaining divided equally between a prolonged remission and a persistently active disease. Treatment goals include long-term patient survival, prevention of flares and organ damage, and optimisation of health-related quality of life. For organ-threatening or life-threatening SLE, treatment usually includes an initial period of high-intensity immunosuppressive therapy to control disease activity, followed by a longer period of less intensive therapy to consolidate response and prevent relapses. Management of disease-related and treatment-related comorbidities, especially infections and atherosclerosis, is of paramount importance. New disease-modifying conventional and biologic agents-used alone, in combination or sequentially-have improved rates of achieving both short-term and long-term treatment goals, including minimisation of glucocorticoid use.


Asunto(s)
Inmunosupresores/uso terapéutico , Lupus Eritematoso Sistémico/terapia , Anemia Hemolítica Autoinmune/fisiopatología , Anemia Hemolítica Autoinmune/terapia , Anticuerpos Monoclonales Humanizados/uso terapéutico , Autoanticuerpos/inmunología , Azatioprina/uso terapéutico , Inhibidores de la Calcineurina/uso terapéutico , Enfermedades Cardiovasculares/epidemiología , Ciclofosfamida/uso terapéutico , Manejo de la Enfermedad , Femenino , Glucocorticoides/uso terapéutico , Enfermedades de las Válvulas Cardíacas/fisiopatología , Enfermedades de las Válvulas Cardíacas/terapia , Humanos , Hidroxicloroquina/uso terapéutico , Hipertensión Pulmonar/fisiopatología , Hipertensión Pulmonar/terapia , Lupus Eritematoso Sistémico/diagnóstico , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/fisiopatología , Nefritis Lúpica/fisiopatología , Nefritis Lúpica/terapia , Vasculitis por Lupus del Sistema Nervioso Central/fisiopatología , Vasculitis por Lupus del Sistema Nervioso Central/terapia , Síndrome de Activación Macrofágica/fisiopatología , Síndrome de Activación Macrofágica/terapia , Metotrexato/uso terapéutico , Ácido Micofenólico/uso terapéutico , Miocarditis/fisiopatología , Miocarditis/terapia , Evaluación de Resultado en la Atención de Salud , Pericarditis/fisiopatología , Pericarditis/terapia , Fenotipo , Embarazo , Complicaciones del Embarazo/epidemiología , Complicaciones del Embarazo/fisiopatología , Complicaciones del Embarazo/terapia , Pronóstico , Púrpura Trombocitopénica Idiopática/fisiopatología , Púrpura Trombocitopénica Idiopática/terapia , Calidad de Vida , Recurrencia , Rituximab/uso terapéutico , Índice de Severidad de la Enfermedad , Tasa de Supervivencia , Neoplasias del Cuello Uterino/epidemiología
7.
Neurology ; 96(5): 214-225, 2021 02 02.
Artículo en Inglés | MEDLINE | ID: mdl-33277411

RESUMEN

Monoclonal gammopathy is encountered quite frequently in the general population. This type of hematologic abnormality may be mild, referred to as monoclonal gammopathy of undetermined significance or related to different types of hematologic malignancies. The association of a peripheral neuropathy with monoclonal gammopathy is also fairly common, and hemopathy may be discovered in an investigation of peripheral neuropathy. In such a situation, it is essential to determine the exact nature of the hematologic process in order not to miss a malignant disease and thus initiate the appropriate treatment (in conjunction with hematologists and oncologists). In this respect, nerve biopsy (discussed on a case-by-case basis) is of great value in the management of such patients. We therefore propose to present the objectives and main interests of nerve biopsy in this situation.


Asunto(s)
Paraproteinemias/fisiopatología , Enfermedades del Sistema Nervioso Periférico/fisiopatología , Anemia Hemolítica Autoinmune/diagnóstico , Anemia Hemolítica Autoinmune/etiología , Anemia Hemolítica Autoinmune/patología , Anemia Hemolítica Autoinmune/fisiopatología , Ataxia/diagnóstico , Ataxia/etiología , Ataxia/patología , Ataxia/fisiopatología , Autoanticuerpos/inmunología , Biopsia , Árboles de Decisión , Electrodiagnóstico , Humanos , Inmunoglobulina A , Inmunoglobulina G , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/complicaciones , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/diagnóstico , Amiloidosis de Cadenas Ligeras de las Inmunoglobulinas/fisiopatología , Inmunoglobulina M , Gammopatía Monoclonal de Relevancia Indeterminada , Glicoproteína Asociada a Mielina/inmunología , Conducción Nerviosa/fisiología , Oftalmoplejía/diagnóstico , Oftalmoplejía/etiología , Oftalmoplejía/patología , Oftalmoplejía/fisiopatología , Síndrome POEMS/diagnóstico , Síndrome POEMS/etiología , Síndrome POEMS/patología , Síndrome POEMS/fisiopatología , Paraproteinemias/complicaciones , Paraproteinemias/diagnóstico , Nervios Periféricos/patología , Nervios Periféricos/ultraestructura , Enfermedades del Sistema Nervioso Periférico/diagnóstico , Enfermedades del Sistema Nervioso Periférico/etiología , Enfermedades del Sistema Nervioso Periférico/patología , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/diagnóstico , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/etiología , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/patología , Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante/fisiopatología , Disautonomías Primarias/diagnóstico , Disautonomías Primarias/etiología , Disautonomías Primarias/patología , Disautonomías Primarias/fisiopatología , Neuropatía de Fibras Pequeñas/diagnóstico , Neuropatía de Fibras Pequeñas/etiología , Neuropatía de Fibras Pequeñas/patología , Neuropatía de Fibras Pequeñas/fisiopatología , Macroglobulinemia de Waldenström
8.
Med. clín (Ed. impr.) ; 154(9): 331-337, mayo 2020. tab
Artículo en Español | IBECS | ID: ibc-193212

RESUMEN

INTRODUCCIÓN: Las anemias hemolíticas autoinmunes (AHAI) son enfermedades poco frecuentes y heterogéneas en su fisiopatología y comportamiento clínico, siendo el manejo de las mismas fundamentalmente empírico. PACIENTES Y MÉTODOS: Realizamos un estudio observacional, retrospectivo y multicéntrico de 93 pacientes diagnosticados de AHAI en 9 hospitales españoles entre 1987 y 2017, con una mediana de seguimiento de 28 meses. RESULTADOS: Mediana de edad de 67 años; un 85% de AHAI por anticuerpos calientes y un 64% AHAI primarias. Los valores de hemoglobina más bajos al diagnóstico se relacionaron con edad<45 años y el tipo serológico IgG+C. Un 92% recibieron tratamiento de primera línea, un 54% de segunda línea y un 27% de tercera línea. Las AHAI calientes fueron tratadas en primera línea con esteroides, con respuestas globales del 83% y completas del 58%. El rituximab en monoterapia o asociado a esteroides se administró a 34 pacientes con respuestas globales cercanas al 100% (respuestas completas 40-60%), relegando la esplenectomía a tercera línea. El tratamiento inmunosupresor se administró en pacientes con enfermedades autoinmunes o en dependientes de corticoides. DISCUSIÓN: Encontramos altas tasas de respuesta a esteroides, con tratamientos muy prolongados que provocan efectos secundarios y corticodependencia en un tercio de los pacientes. La asociación de esteroides con rituximab en primera línea podría estar indicada en pacientes con bajos niveles de hemoglobina y tipo serológico IgG+C. Las altas tasas de recaída hacen necesario el desarrollo de estudios aleatorizados con nuevos fármacos o la asociación con los ya existentes, que permitan mayor duración de las respuestas y con menores efectos secundarios


INTRODUCTION: Autoimmune haemolytic anaemia (AIHA) is an infrequent and heterogeneous disease in its pathophysiology and clinical behaviour, therefore it is generally managed empirically. PATIENTS AND METHODS: We conducted an observational, retrospective and multicentre study of 93 patients diagnosed with AHAI in 9 Spanish hospitals between 1987 and 2017, with a median follow-up of 28 months. RESULTS: Median age of 67 years; 85% AHAI for hot antibodies and 64% primary AHAI. The lowest haemoglobin values at diagnosis related to patients under 45 years of age and serological type IgG+C. Of the patients, 92% received first line treatment, 54% second line, and 27% third line. The warm AHAI were treated in first line with steroids, with overall responses of 83% and complete of 58%. Rituximab in monotherapy or in association with steroids was administered to 34 patients with overall responses close to 100% (complete responses 40-60%), relegating splenectomy to the third line. The immunosuppressive treatment was administered in patients with autoimmune diseases or in corticoid-dependent patients. DISCUSSION: We found high rates of response to steroids, with very prolonged treatments that cause side effects and corticoid dependence in a third of patients. The combination of steroids with rituximab in the first line, could be indicated in patients with low levels of haemoglobin and serological type IgG+C. The high relapse rates make necessary the development of randomised studies with new drugs or the combination with existing ones, which allow longer response times and with fewer side effects


Asunto(s)
Humanos , Masculino , Femenino , Lactante , Preescolar , Niño , Adolescente , Adulto Joven , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Anemia Hemolítica Autoinmune/diagnóstico , Anemia Hemolítica Autoinmune/tratamiento farmacológico , Inmunosupresores , Resultado del Tratamiento , Anemia Hemolítica Autoinmune/fisiopatología , Estudios Retrospectivos , Enfermedades Autoinmunes/tratamiento farmacológico , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos , Glucocorticoides/administración & dosificación
9.
Front Immunol ; 11: 590, 2020.
Artículo en Inglés | MEDLINE | ID: mdl-32318071

RESUMEN

Autoimmune hemolytic anemias mediated by cold agglutinins can be divided into cold agglutinin disease (CAD), which is a well-defined clinicopathologic entity and a clonal lymphoproliferative disorder, and secondary cold agglutinin syndrome (CAS), in which a similar picture of cold-hemolytic anemia occurs secondary to another distinct clinical disease. Thus, the pathogenesis in CAD is quite different from that of polyclonal autoimmune diseases such as warm-antibody AIHA. In both CAD and CAS, hemolysis is mediated by the classical complement pathway and therefore can result in generation of anaphylotoxins, such as complement split product 3a (C3a) and, to some extent, C5a. On the other hand, infection and inflammation can act as triggers and drivers of hemolysis, exemplified by exacerbation of CAD in situations with acute phase reaction and the role of specific infections (particularly Mycoplasma pneumoniae and Epstein-Barr virus) as causes of CAS. In this review, the putative mechanisms behind these phenomena will be explained along with other recent achievements in the understanding of pathogenesis in these disorders. Therapeutic approaches have been directed against the clonal lymphoproliferation in CAD or the underlying disease in CAS. Currently, novel targeted treatments, in particular complement-directed therapies, are also being rapidly developed and will be reviewed.


Asunto(s)
Anemia Hemolítica Autoinmune/inmunología , Anemia Hemolítica Autoinmune/fisiopatología , Anemia Hemolítica Autoinmune/terapia , Crioglobulinas/inmunología , Hemólisis/inmunología , Humanos
10.
Medicine (Baltimore) ; 99(2): e18739, 2020 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-31914091

RESUMEN

Autoimmune hemolytic anemia (AIHA) is a rare disease in which autoantibodies target red blood cells (RBCs), leading to anemia that ranges from no symptoms to severe life-threatening hemolysis. Little is known about the severity of anemia, blood transfusion efficiency and risk of transfusion-related reactions among hospitalized AIHA patients, especially in those with incompatible RBC transfusions.A retrospective study was conducted among hospitalized AIHA patients from January 2009 to December 2015 in a large tertiary care medical center in southwest China.A total of 450 AIHA hospitalized patients were recruited, of whom 97.3% had warm AIHA, 30.3% had primary AIHA, and 90.7% were treated with corticosteroids. On admission, approximately 3% of patients had an hemoglobin (Hb) <30 g/L, 34% had an Hb between 30 and 59.9 g/L, and 46% had an Hb ranging from 60 to 89.9 g/L. A total of 2509.5 U RBCs were transfused to AIHA patients, and 14 transfusion-related adverse reactions were recorded, without any hemolytic transfusion reactions. With an average transfusion trigger of 52.0 ±â€Š9.3 g/L, 59.7% of the patients received RBCs, and 55.8% of the transfusions were viewed as effective. Least incompatible RBCs were given in 39% of the transfusions, but the transfusion efficiency did not significantly decrease with these incompatible blood transfusions (P = .253). Primary AIHA patients with a nadir Hb of approximately 40 to 50 g/L during their hospital stay had the highest rate of remission and did not require a different total number of RBC transfusions (P = .068) or length of hospitalization (P = .194) compared to other groups with nadir Hb values <30 g/L, ≥30 and <40 g/L, ≥50 and <60 g/L, and ≥60 g/L.One-third of AIHA patients suffered from severe anemia during hospitalization, and transfusions, even with incompatible RBCs, were safe and efficient. However, transfusion triggers between 40 and 50 g/L seemed to benefit the most patients by alleviating the RBC destruction caused by autoantibodies, and a restrictive transfusion strategy was beneficial in AIHA patients.


Asunto(s)
Corticoesteroides/uso terapéutico , Anemia Hemolítica Autoinmune/fisiopatología , Anemia Hemolítica Autoinmune/terapia , Transfusión de Eritrocitos/métodos , Corticoesteroides/administración & dosificación , Corticoesteroides/efectos adversos , Adulto , Anemia Hemolítica Autoinmune/epidemiología , Transfusión de Eritrocitos/efectos adversos , Femenino , Hemoglobinas , Humanos , Masculino , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Índice de Severidad de la Enfermedad , Reacción a la Transfusión/epidemiología
12.
BMJ Case Rep ; 12(5)2019 May 21.
Artículo en Inglés | MEDLINE | ID: mdl-31118169

RESUMEN

A 46-year-old man was admitted to the emergency department with fever and pleuritic thoracic pain. Six weeks prior to admission, the patient had undergone cardiac surgery. The ECG showed diffuse ST segment elevation and PR segment depression. The blood tests revealed increased inflammatory markers and negative myocardial necrosis markers. Pericardial and left-sided pleural effusion were noted. Sterile blood cultures were negative. Hence, the hypothesis of Dressler's syndrome was established. The patient improved clinically and analytically with a short course of anti-inflammatory therapy and was discharged with colchicine and acetylsalicylic acid. A thoracic radiography performed 2 months after showed complete remission of pleural effusion.


Asunto(s)
Anemia Hemolítica Autoinmune/diagnóstico , Anemia Hemolítica Autoinmune/fisiopatología , Derrame Pericárdico/etiología , Cuidados Posteriores , Anemia Hemolítica Autoinmune/sangre , Anemia Hemolítica Autoinmune/tratamiento farmacológico , Antiinflamatorios/uso terapéutico , Diagnóstico Diferencial , Electrocardiografía , Humanos , Masculino , Persona de Mediana Edad , Infarto del Miocardio/metabolismo , Derrame Pericárdico/diagnóstico por imagen , Pericarditis/diagnóstico por imagen , Pericarditis/etiología , Resultado del Tratamiento
13.
Trop Doct ; 49(1): 54-55, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30293518

RESUMEN

Autoimmune haemolytic anaemia due to malaria or following its treatment with artesunate is rare. A child presented with severe anaemia after being treated with artesunate for P. vivax malaria. Blood transfusion was difficult as cross-matching showed major incompatibility; group O negative blood under the cover of steroids was transfused. Oral steroids were given for six weeks. The patient made a complete recovery.


Asunto(s)
Anemia Hemolítica Autoinmune/etiología , Antimaláricos/efectos adversos , Malaria Vivax/complicaciones , Malaria Vivax/tratamiento farmacológico , Anemia Hemolítica Autoinmune/diagnóstico , Anemia Hemolítica Autoinmune/fisiopatología , Anemia Hemolítica Autoinmune/terapia , Antimaláricos/uso terapéutico , Transfusión Sanguínea , Humanos , India , Lactante , Malaria Vivax/diagnóstico , Malaria Vivax/fisiopatología , Masculino , Plasmodium vivax/efectos de los fármacos , Plasmodium vivax/aislamiento & purificación , Esteroides/administración & dosificación , Resultado del Tratamiento
14.
J Med Case Rep ; 12(1): 380, 2018 Dec 26.
Artículo en Inglés | MEDLINE | ID: mdl-30585141

RESUMEN

BACKGROUND: Gastric duplication cysts are uncommon congenital anomalies found primarily in children and rarely seen in the adult population. Accurate diagnosis of cysts before resection is difficult even using the most advanced imaging techniques. CASE PRESENTATION: In this report, we describe a 28-year-old Moroccan patient with a history of autoimmune hemolytic anemia who presented with an asymptomatic abdominal cystic mass detected during abdominal computed tomography performed before splenectomy. Magnetic resonance imaging performed for accurate characterization showed a high-signal-intensity cystic mass on T2-weighted images, located between the patient's stomach and spleen. The patient underwent a complete cyst resection during exploratory laparotomy. The histological examination showed a cyst lined by three different epithelia with bundles of smooth muscle, which suggested a gastric duplication cyst. CONCLUSIONS: We report a case of gastric cyst duplication in an adult with autoimmune hemolytic anemia, and we discuss this rare association, radiological findings, and the unique histological findings of this case.


Asunto(s)
Anemia Hemolítica Autoinmune/terapia , Quistes/patología , Bazo/patología , Esplenectomía , Gastropatías/patología , Adulto , Anemia Hemolítica Autoinmune/fisiopatología , Quistes/diagnóstico por imagen , Humanos , Imagen por Resonancia Magnética , Masculino , Inducción de Remisión , Bazo/diagnóstico por imagen , Gastropatías/diagnóstico por imagen , Tomografía Computarizada por Rayos X , Resultado del Tratamiento
16.
Semin Hematol ; 55(3): 141-149, 2018 07.
Artículo en Inglés | MEDLINE | ID: mdl-30032751

RESUMEN

The classical complement pathway and, to some extent, the terminal pathway, are involved in the immune pathogenesis of autoimmune hemolytic anemia (AIHA). In primary cold agglutinin disease (CAD), secondary cold agglutinin syndrome and paroxysmal cold hemoglobinuria, the hemolytic process is entirely complement dependent. Complement activation also plays an important pathogenetic role in some warm-antibody AIHAs, especially when immunoglobulin M is involved. This review describes the complement-mediated hemolysis in AIHA with a major focus on CAD, in which activation of the classical pathway is essential and particularly relevant for complement-directed therapy. Several complement inhibitors are candidate therapeutic agents in CAD and other AIHAs, and some of these drugs seem very promising. The relevant in vitro findings, early clinical data and future perspectives are reviewed.


Asunto(s)
Anemia Hemolítica Autoinmune/fisiopatología , Activación de Complemento/genética , Humanos
17.
Am J Vet Res ; 79(5): 518-524, 2018 May.
Artículo en Inglés | MEDLINE | ID: mdl-29688778

RESUMEN

OBJECTIVE To compare blood flow velocities of the portal vein (PV) and caudal vena cava (CVC) measured by use of pulsed-wave Doppler ultrasonography in clinically normal dogs and dogs with primary immune-mediated hemolytic anemia (IMHA). ANIMALS 11 client-owned dogs admitted to a veterinary teaching hospital for management of primary IMHA and 21 staff- or student-owned clinically normal dogs. PROCEDURES Flow velocities in the PV and CVC at the porta hepatis were evaluated in conscious unsedated dogs with concurrent ECG monitoring; evaluations were performed before dogs with IMHA received heparin or blood transfusions. Three measurements of peak velocity at end expiration were obtained for each vessel, and the mean was calculated. Results were compared between IMHA and control groups. RESULTS Mean ± SD blood flow velocity in the CVC differed between control (63.0 ± 18.6 cm/s) and IMHA (104 ± 36.9 cm/s) groups. Variance in dogs with IMHA was significantly greater than that for the clinically normal dogs. No significant difference in blood flow velocity in the PV was detected between IMHA and control dogs. CONCLUSIONS AND CLINICAL RELEVANCE Higher blood flow velocities were detected by use of pulsed-wave Doppler ultrasonography in the CVC of dogs with naturally occurring IMHA and may be used to predict anemia in patients suspected of having IMHA.


Asunto(s)
Anemia Hemolítica Autoinmune/diagnóstico por imagen , Anemia Hemolítica Autoinmune/fisiopatología , Velocidad del Flujo Sanguíneo , Enfermedades de los Perros/sangre , Vena Porta/diagnóstico por imagen , Vena Porta/fisiopatología , Animales , Perros , Femenino , Hemodinámica , Masculino , Análisis de Regresión , Respiración , Ultrasonografía Doppler
18.
BMJ Case Rep ; 20182018 Jan 31.
Artículo en Inglés | MEDLINE | ID: mdl-29386216

RESUMEN

Spur cell haemolytic anaemia (SCA) is a form of anaemia that can be seen in patients with severely impaired liver function or advanced cirrhosis. It is associated with high mortality. The treatment options for SCA secondary to cirrhosis are limited. Our patient is a middle-aged man who developed SCA and was not a candidate for liver transplantation or splenectomy. High-dose steroids helped ameliorate haemolysis and improve anaemia and general condition of our patient.


Asunto(s)
Anemia Hemolítica Autoinmune/tratamiento farmacológico , Glucocorticoides/administración & dosificación , Glucocorticoides/uso terapéutico , Metilprednisolona/uso terapéutico , Esteroides/administración & dosificación , Esteroides/uso terapéutico , Lesión Renal Aguda/diagnóstico , Lesión Renal Aguda/fisiopatología , Lesión Renal Aguda/terapia , Anciano , Anemia Hemolítica Autoinmune/diagnóstico , Anemia Hemolítica Autoinmune/fisiopatología , Mareo , Humanos , Hepatopatías/diagnóstico , Hepatopatías/fisiopatología , Hepatopatías/terapia , Masculino , Metilprednisolona/administración & dosificación , Enfermedad del Hígado Graso no Alcohólico/fisiopatología , Resultado del Tratamiento
20.
Pathol Res Pract ; 213(5): 585-589, 2017 May.
Artículo en Inglés | MEDLINE | ID: mdl-28215645

RESUMEN

Certain autoimmune conditions are associated with an increased risk of lymphoid malignancy. We report a 65-year old patient with autoimmune hemolytic anemia (AIHA) complicated by a follicular lymphoma (FL) in situ and other B-cell clones in the spleen. This diagnosis was made by immunohistochemistry, flow cytometry, and Southern blot analysis of the B-cell receptor. Chromosomal analysis revealed 46,XX,t(14;18)(q32;q21) 2/20, 46,XX,del(7)(q?),del(11)(q?) 2/20, and 46,XX 16/20. It has been speculated that these preneoplastic conditions do not progress to overt FL and other lymphomas without a second lymphomagenic insult. However, AIHA confers a 27.4-fold higher risk of such an insult leading to lymphoma compared with the normal healthy population. Without any therapy after splenectomy, our current study patient remained healthy with no lymphoma development for 28 months. Based on this case, we discuss the pathophysiology of lymphomagenesis in a spleen with AIHA and the roles of a splenectomy for preventing further lymphomagenesis in AIHA patients.


Asunto(s)
Anemia Hemolítica Autoinmune/diagnóstico , Hepatitis C/complicaciones , Linfoma Folicular/diagnóstico , Anciano , Anemia Hemolítica Autoinmune/complicaciones , Anemia Hemolítica Autoinmune/fisiopatología , Anemia Hemolítica Autoinmune/virología , Linfocitos B/patología , Southern Blotting , Femenino , Citometría de Flujo , Hepatitis C/patología , Hepatitis C/fisiopatología , Hepatitis C/virología , Humanos , Inmunohistoquímica , Linfoma Folicular/complicaciones , Linfoma Folicular/fisiopatología , Linfoma Folicular/virología , Bazo/patología , Esplenectomía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA